BioInsights - BioInsights

CELL & GENE THERAPY INSIGHTS

October 2023 Issue

Vol 1 Issue 3

April 2023

Featuring this month's spotlight content:

April 2023
View
Cell & Gene Therapy Vol 1 Issue 3
View

Latest Articles

New Article

New Article

Elisa Manzotti, Paul Manzotti
1 January 2024
Expert Insight
Coming of age: taking the next steps with non-viral gene delivery

Coming of age: taking the next steps with non-viral gene delivery

Matt Stanton
9 May 2023
Interview
Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Paolo Ascierto
3 May 2023
Interview
Transfection optimization for AAV production

Transfection optimization for AAV production

Peter Boyce
2 May 2023
Interview
Viral vector production

Viral vector production

Peter Boyce
1 May 2023
FastFacts
A fresh look at analytical methods for vaccines

A fresh look at analytical methods for vaccines

8 March 2023
Commentary
From cells to purified capsids: How to develop a scalable rAAV process

From cells to purified capsids: How to develop a scalable rAAV process

Asa McWhirter
11 June 2022
Commentary
Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Alexander EGGERMONT
29 March 2022
Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

29 March 2022
Application Note

Channel content

Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Assessing the evolving AAV preclinical safety landscape in 2023 & beyond

Paolo Ascierto
3 May 2023
Interview
Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Alexander EGGERMONT
29 March 2022
Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

Quantifying the tumor microenvironment: what is the next step to advance cancer immunotherapy?

29 March 2022
Application Note
View channel
New Article

New Article

Elisa Manzotti
1 January 2024
Expert Insight
Coming of age: taking the next steps with non-viral gene delivery

Coming of age: taking the next steps with non-viral gene delivery

Matt Stanton
9 May 2023
Interview
A fresh look at analytical methods for vaccines

A fresh look at analytical methods for vaccines

8 March 2023
Commentary
View channel
Regulatory & supply chain implications for plasmids as critical starting materials in the manufacture of viral vector gene therapy products

Regulatory & supply chain implications for plasmids as critical starting materials in the manufacture of viral vector gene therapy products

14 March 2022
Scalable AAV manufacturing: addressing challenges across the workflow

Scalable AAV manufacturing: addressing challenges across the workflow

editor
18 January 2021
Innovator Insight
1Viral vector production process intensification: analytics, automation, in-line testing, and more

1Viral vector production process intensification: analytics, automation, in-line testing, and more

M DiBiasio-White, F Gerner, J Tate et al.
18 January 2021
Expert Roundtable Video
View channel
A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021

A year like no other: reflecting on the challenges of 2020, and looking to regain momentum for cell and gene therapy in 2021

Peter Marks
8 January 2021
Interview
Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives

Exosomes as therapeutics and drug delivery vehicles: global regulatory perspectives

Shaun Stapleton
17 December 2020
Perspective
How to standardize quality requirements of raw materials

How to standardize quality requirements of raw materials

Bernd Leistler
1 December 2020
Editorial
View channel
New Article

New Article

Elisa Manzotti
1 January 2024
Expert Insight
Abbreviated in-house qualification of real time mycoplasma detection kit

Abbreviated in-house qualification of real time mycoplasma detection kit

Sowmya Viswanathan
7 January 2021
On Demand Webinar
Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Celyad Oncology’s case study: validation approach for accelerated mycoplasma testing

Sarah Snykers
7 January 2021
On Demand Webinar
View channel
Guiding America througha pandemic

Guiding America througha pandemic

A Fauci, C Yilmaz, C Yi et al.
19 May 2022
Interview
Scalable upstream process development for the suspension-based production of lentiviral vectors for CAR T cell therapies with multiparallel & benchtop bioreactor systems & DoE methodology

Scalable upstream process development for the suspension-based production of lentiviral vectors for CAR T cell therapies with multiparallel & benchtop bioreactor systems & DoE methodology

D Riethmüller, D Nyamay’antu, D Bollmann
16 July 2021
Innovator Insight
An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

Leszek Lisowski, Wendy Gold
23 December 2020
Interview
View channel
What to expect in 2021: seven cell and gene therapy commercialization trends

What to expect in 2021: seven cell and gene therapy commercialization trends

Heidi Hagen
10 December 2020
Innovator Insight
View channel
From cells to purified capsids: How to develop a scalable rAAV process

From cells to purified capsids: How to develop a scalable rAAV process

Asa McWhirter
11 June 2022
Commentary
View channel